Clinical Significance of VEGF-A and MVD Detection in Stage Ⅱ Colorectal Cancer Tissue
董丹凤,李恩孝,王举波,吴胤瑛,施璠,郭俊俊,陈旭
DOI: https://doi.org/10.3969/j.issn.1009-0460.2010.02.005
2010-01-01
Chinese Clinical Oncology
Abstract:Objective To study the clinical significance of VEGF-A and MVD detection in stageⅡcolorectal cancer tissue.Methods VEGF-A and MVD in 56 stageⅡcolorectal cancer postoperative tissues and 13 normal colorectal tissues were detectd by immunohistochemical technique,the relationship between VEGF-A,MVD and clinicopathological characteristics,prognosis in stageⅡcolorectal cancer patients was analyzed by SPSS16.0 software.Results(1) VEGF-A expression and MVD in cancer tissue were obviously higher than in normal tissue(64.3% vs.0,P=0.000;23.69±5.779 vs.7.9±1.27,P=0.000).VEGF-A expression in cancer tissue of patients with different tumor size had statistical difference(85.0% vs.52.8%,P=0.034),VEGF-A expression in tissue of patients who relapsed or did not finally also had statistical difference(57.1% vs.28.9%,P=0.039).MVD in tissue of patients with different age and tumor differentiation had statistical difference(27.36±5.658 vs.21.67±4.959,P=0.001;27.65±6.329 vs.23.16±5.416,P=0.013),MVD in tissue of patients who relapsed or did not finally also had statistical difference(28.94±4.208 vs.22.41±5.428,P=0.000).MVD in the group of VEGF-A negative and weak positive,strong positive had statistical difference(21.80±4.60 vs.24.51±5.07,P=0.027;21.80±4.60 vs.25.79±3.78,P=0.006).(2) 1-,3-,5-year survival rates of 56 stage Ⅱcolorectal cancer patients seperately were 98.23%,87.37% and 75.96%.The expression of VEGF-A in cancer tissue had relationship with DFS(χ2=8.570,P=0.014,r=-0.292) and OS(χ2=6.502,P=0.039,r=-0.281),MVD in cancer tissue also had relationship with DFS(χ2=6.806,P=0.032,r=-0.213),but had no statistical relationship with OS(χ2=1.902,P=0.351,r=-0.022).Conclusion There is a relationship between VEGF-A expression and MVD,they are also related with clinicopathological characteristics and prognosis,and could provide some useful reference in comprehensive therapy of stageⅡcolorectal cancer patients.